Assessment of mental ability in elderly anticoagulated patients: its reduction is associated with a less satisfactory quality of treatment

被引:15
作者
Palareti, G
Poggi, M
Guazzaloca, G
Savino, A
Coccheri, S
机构
[1] Department of Angiology and Blood Coagulation, University Hospital S. Orsola-Malpighi, 40138 Bologna
[2] Department of Angiology and Blood Coagulation, University Hospital S. Orsola, 40138 Bologna
关键词
oral anticoagulants; mental ability; elderly; anticoagulation clinics; overanticoagulation; compliance;
D O I
10.1097/00001721-199710000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mental capacity was assessed in 311 apparently self-sufficient patients (greater than or equal to 60 years of age, 170 men) under stabilised oral anticoagulant treatment (OAT) by administering the Hodkinson's Abbreviated Mental Test (AMT). The international normalized ratios (INR) recorded during the 3 months before and the 3 after the date of test administration were examined by the INR-Day software program. The percentage of time spent within, below or above the intended therapeutic range was calculated in patients who scored abnormally at AMT, and compared with matched controls with normal AMT results. Forty patients [12.9%; 28 women (19.8%) and 12 men (7.1%), P < 0.0011] had abnormal AMT results; the rate seemed to increase with age. Most of these patients (35, 75%) had only elementary education. Patients with abnormal AMT results spent more time outside the intended therapeutic ranges than 40 matched controls (20.9% of the observed time vs 13.7%, P < 0.0001; odds ratio 1.68, CI 1.53-1.84). Unsuspected reduction of mental ability or attention levels was found in a number of elderly patients receiving OAT; these patients presented longer periods of either under- or over-anticoagulation and were, therefore, exposed to a higher risk of thrombotic or bleeding complications. Anticoagulation clinics would be advised to assess mental abilities in elderly patients before starting OAT.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 20 条
[1]   ANTICOAGULANTS IN OLDER PATIENTS - A SAFETY PERSPECTIVE [J].
BEYTH, RJ ;
LANDEFELD, CS .
DRUGS & AGING, 1995, 6 (01) :45-54
[2]   ASSOCIATION BETWEEN QUANTITATIVE MEASURES OF DEMENTIA AND OF SENILE CHANGE IN CEREBRAL GREY MATTER OF ELDERLY SUBJECTS [J].
BLESSED, G ;
TOMLINSON, BE ;
ROTH, M .
BRITISH JOURNAL OF PSYCHIATRY, 1968, 114 (512) :797-+
[3]  
COLVIN BT, 1990, J CLIN PATHOL, V43, P177
[4]   THERAPEUTIC CONTROL OF ANTICOAGULANT TREATMENT [J].
DUXBURY, BM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1634-1635
[5]   The risk for and severity of bleeding complications in elderly patients treated with warfarin [J].
Fihn, SD ;
Callahan, CM ;
Martin, DC ;
McDonell, MB ;
Henikoff, JG ;
White, RH .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) :970-+
[6]   AGING AND THE ANTICOAGULANT RESPONSE TO WARFARIN THERAPY [J].
GURWITZ, JH ;
AVORN, J ;
ROSSDEGNAN, D ;
CHOODNOVSKIY, I ;
ANSELL, J .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (11) :901-904
[7]  
HARRIES AD, 1981, LANCET, V1, P1320
[8]   GUIDE TO ANTICOAGULANT-THERAPY .2. ORAL ANTICOAGULANTS [J].
HIRSH, J ;
FUSTER, V .
CIRCULATION, 1994, 89 (03) :1469-1480
[9]  
HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233
[10]  
*IT FED ANT CLIN F, 1996, NUOV GUID TER CON AN